Please use this identifier to cite or link to this item:
|Title:||Transcriptomic analysis of pluripotent stem cells: Insights into health and disease|
|Keywords:||Embryonic stem cells|
Induced pluripotent stem cells
|Source:||Yeo, J.-C., Ng, H.-H. (2011-10-27). Transcriptomic analysis of pluripotent stem cells: Insights into health and disease. Genome Medicine 3 (10) : -. ScholarBank@NUS Repository. https://doi.org/10.1186/gm284|
|Abstract:||Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) hold tremendous clinical potential because of their ability to self-renew, and to differentiate into all cell types of the body. This unique capacity of ESCs and iPSCs to form all cell lineages is termed pluripotency. While ESCs and iPSCs are pluripotent and remarkably similar in appearance, whether iPSCs truly resemble ESCs at the molecular level is still being debated. Further research is therefore needed to resolve this issue before iPSCs may be safely applied in humans for cell therapy or regenerative medicine. Nevertheless, the use of iPSCs as an in vitro human genetic disease model has been useful in studying the molecular pathology of complex genetic diseases, as well as facilitating genetic or drug screens. Here, we review recent progress in transcriptomic approaches in the study of ESCs and iPSCs, and discuss how deregulation of these pathways may be involved in the development of disease. Finally, we address the importance of these advances for developing new therapeutics, and the future challenges facing the clinical application of ESCs and iPSCs. © 2011 BioMed Central Ltd.|
|Source Title:||Genome Medicine|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Feb 27, 2018
WEB OF SCIENCETM
checked on Feb 19, 2018
checked on Mar 12, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.